Adding cetuximab to capecitabine plus oxaliplatin (XELOX) in first-line treatment of metastatic colorectal cancer: a randomized phase II trial of the Swiss Group for Clinical Cancer Research SAKK. (Q37113071)
scientific article published on 17 March 2008
Language:
(P31) (Q13442814)
(P304) 1288-1292
(P433) 7
(P478) 19
(P577) Monday, March 17, 2008
(P921) (Q42824440)
(Q188874)
(Q420296)
(Q422327)
(Q108566365)
(Q25493920)
(Q420207)
(P1433) (Q326122)
(P1476) "Adding cetuximab to capecitabine plus oxaliplatin (XELOX) in first-line treatment of metastatic colorectal cancer: a randomized phase II trial of the Swiss Group for Clinical Cancer Research SAKK." (language: en)
(P2093) M Borner
D Koeberle
R Von Moos
P Saletti
D Rauch
V Hess
A Trojan
D Helbling
B Pestalozzi
C Caspar
T Ruhstaller
A Roth
A Kappeler
D Dietrich
D Lanz
W Mingrone
Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland
(P2860) (Q29616236)
(Q27860681)
(Q27824811)
(Q36557269)
(Q43937160)
(Q33978749)
(Q44313163)
(Q34554584)
(Q27860904)
(Q44339739)
(Q43871119)
(Q46892017)
(Q46903224)
other details
description scientific article published on 17 March 2008

External Links